Administration of vaccines after temperature excursion; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men B NVS (Bexsero) (batch number 94BF5, expiry date 31st March 2024) and (batch number ABKC05A, expiry date March 2023) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) (batch number 3A745, expiry date November 2024) and (batch number G7749, expiry date 14th March 2024) for prophylaxis, dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) (batch number ZH575, expiry date 12th September 2022) and (batch number C2L22, expiry date 12th May 2024) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) (batch number 3M9Y7, expiry date 3rd March 2024) and (batch number 23T73, expiry date 30th April 2023) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) (batch number X9HS4, expiry date 25th March 2024) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 26th August 2022, the patient received Bexsero. On an unknown date, the dose was an unknown dose. On 26th August 2022, the patient started Bexsero Pre-Filled Syringe Device and Boostrix. On an unknown date, the dose was an unknown dose. On 26th August 2022, the patient started Boostrix Pre-Filled Syringe Device and Engerix B. On an unknown date, the dose was an unknown dose. On 26th August 2022, the patient started Engerix B Pre-Filled Syringe Device and Infanrix. On an unknown date, the dose was an unknown dose. On 26th August 2022, the patient started Infanrix Pre-Filled Syringe Device, Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero, Bexsero Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 19-OCT-2022 Reporter's Comment: The nurse reported that the patients received a dose of Bexsero, Boostrix, Engerix B, Infanrix and Kinrix that were exposed to a minimum temperature of 30.2 Degree Fahrenheit. The health care professional reported that these vaccines were administered to patients (did not have patient´s information or any other details at hand when asked) The vaccine administration facility was the same as primary reporter. The reporter consented to follow up by email. Additional Supportive Information: The patient received a dose of Bexsero, Boostrix, Engerix B, Infanrix and Kinrix involved in a temperature excursion, which led to incorrect storage of drug. Note-November 2024 was captured as expiry date as month ends on 30th November 2024 but the expiry date was given as 31st November 2024.